These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005. Brady JE; Sun LS; Rosenberg H; Li G Anesth Analg; 2009 Oct; 109(4):1162-6. PubMed ID: 19762744 [TBL] [Abstract][Full Text] [Related]
43. Malignant hyperthermia: a potentially fatal complication of anesthesia. Stolworthy C; Haas RE Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843 [TBL] [Abstract][Full Text] [Related]
45. Malignant hyperthermia. Cause and treatment. Lieding KG; Graham MD Arch Otolaryngol; 1981 Dec; 107(12):758-60. PubMed ID: 7316859 [TBL] [Abstract][Full Text] [Related]
46. Xenon anaesthesia in a patient with susceptibility to malignant hyperthermia: A case report. Carlomagno M; Esposito C; Marra A; Vargas M; Corcione A Eur J Anaesthesiol; 2016 Feb; 33(2):147-50. PubMed ID: 26164252 [No Abstract] [Full Text] [Related]
47. Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update. Barnes C; Stowell KM; Bulger T; Langton E; Pollock N Anaesth Intensive Care; 2015 Jan; 43(1):98-104. PubMed ID: 25579296 [TBL] [Abstract][Full Text] [Related]
50. The diagnostic dilemma of intraoperative hyperpyrexia in a malaria endemic area. Amanor-Boadu SD; Mohammed A West Afr J Med; 2003; 22(1):98-100. PubMed ID: 12769319 [TBL] [Abstract][Full Text] [Related]
51. Postoperative malignant hyperthermia episodes in patients who received "safe" anaesthetics. Grinberg R; Edelist G; Gordon A Can Anaesth Soc J; 1983 May; 30(3 Pt 1):273-6. PubMed ID: 6336548 [TBL] [Abstract][Full Text] [Related]
54. Heat-exercise hyperpyrexia. Dickinson JG J R Army Med Corps; 1989 Feb; 135(1):27-9. PubMed ID: 2926725 [TBL] [Abstract][Full Text] [Related]
55. Malignant hyperthermia syndrome in an anxious patient. Fletcher R; Ranklev E; Olsson AK; Leander S Br J Anaesth; 1981 Sep; 53(9):993-5. PubMed ID: 7284227 [TBL] [Abstract][Full Text] [Related]
56. Malignant hyperpyrexia: A role for the community physician. Ellis FR; Richards ID Community Med; 1984 May; 6(2):136-9. PubMed ID: 6734141 [No Abstract] [Full Text] [Related]
57. Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients. Bilmen JG; Gillies RI Anaesth Intensive Care; 2014 Jan; 42(1):51-8. PubMed ID: 24471664 [TBL] [Abstract][Full Text] [Related]
58. Malignant hyperthermia and the dental practitioner. Carey CM J Dent Assoc S Afr; 1988 Jan; 43(1):14-5. PubMed ID: 3269059 [No Abstract] [Full Text] [Related]